Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | +9.09% | -7.69% | +11.63% |
Mar. 27 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Satellos Bioscience Announces FY 2023 Results | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 39.55M 54.06M |
---|---|---|---|---|---|
Net income 2024 * | -15M -20.5M | Net income 2025 * | -11M -15.04M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.53
x | P/E ratio 2025 * |
-2.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.44% |
1 day | +9.09% | ||
1 week | -7.69% | ||
Current month | -3.03% | ||
3 months | +2.13% | ||
6 months | +35.21% | ||
Current year | +11.63% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Gleeson
FOU | Founder | 68 | 17-12-31 |
Michael Rudnicki
FOU | Founder | - | 17-12-31 |
Director of Finance/CFO | - | 23-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | - |
Geoff MacKay
CHM | Chairman | 57 | 18-08-31 |
William McVicar
BRD | Director/Board Member | 66 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.48 | +9.09% | 29,150 |
24-04-25 | 0.44 | -4.35% | 49,000 |
24-04-24 | 0.46 | -6.12% | 57,500 |
24-04-23 | 0.49 | +2.08% | 31,580 |
24-04-22 | 0.48 | -7.69% | 29,100 |
Delayed Quote Toronto S.E., April 26, 2024 at 02:55 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 39.55M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MSCL Stock